UnitedHealth Faces Class-Action Lawsuit Over AI-Driven Medicare Denials

Key Facts

Amid rising concerns over AI ethics in healthcare, UnitedHealth Group is facing a class-action lawsuit alleging the use of a flawed algorithm to systematically deny medically necessary care. The complaint claims the company deployed a tool called nH Predict, which reportedly has a 90% error rate, to override physician recommendations for Medicare Advantage patients. According to reports, the lawsuit suggests the company prioritized profit by banking on the fact that very few patients appeal these automated denials.

This legal challenge highlights the significant regulatory and reputational risks for mega-cap insurers integrating AI into clinical decision-making. Per market data, UnitedHealth's reliance on automated systems is now under intense judicial scrutiny in Minnesota, with discovery proceedings ongoing. The case details instances where families were forced to pay substantial out-of-pocket costs after the AI tool allegedly restricted patient stays to within narrow margins of its projections, regardless of medical necessity.

Regarding market performance, UNH stood at $374.14 (close September 18, 2026), having traded between a day high of $376.865 and a low of $372.42. Investors should monitor the ongoing discovery phase for potential financial or regulatory fallout. While the upcoming economic calendar shows no direct healthcare catalysts in the immediate seven-day window, the progression of this federal lawsuit remains a primary focal point for the stock's risk profile.